Freeline Therapeutics Holdings plc carries a market capitalization of 28.28M, placing it among publicly traded companies globally.
| Market Cap | 28.28M |
| Enterprise Value | N/A |
Freeline Therapeutics Holdings plc's stock has gained approximately 3.01587% over the past 52 weeks. The 50-day moving average sits at 6.40, while the 200-day moving average is 4.57.
| Beta (5Y) | N/A |
| 52-Week Price Change | 3.01587% |
| 50-Day Moving Average | 6.40 |
| 200-Day Moving Average | 4.57 |
| Average Volume (20 Days) | N/A |
Freeline Therapeutics Holdings plc's most recent stock split took place on May 12, 2023 with a 15:1 split ratio.
| Last Split Date | 5/12/2023 |
| Split Ratio | 15:1 |